"Hepacivirus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species.
| Descriptor ID |
D016174
|
| MeSH Number(s) |
B04.450.410 B04.820.250.475
|
| Concept/Terms |
Hepacivirus- Hepacivirus
- Hepaciviruses
- Hepatitis C-Like Viruses
- Hepatitis C Like Viruses
- Hepatitis C-Like Virus
|
Below are MeSH descriptors whose meaning is more general than "Hepacivirus".
Below are MeSH descriptors whose meaning is more specific than "Hepacivirus".
This graph shows the total number of publications written about "Hepacivirus" by people in this website by year, and whether "Hepacivirus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 1 | 4 |
| 2004 | 8 | 0 | 8 |
| 2005 | 5 | 3 | 8 |
| 2006 | 2 | 2 | 4 |
| 2007 | 5 | 3 | 8 |
| 2008 | 4 | 2 | 6 |
| 2009 | 4 | 3 | 7 |
| 2010 | 7 | 1 | 8 |
| 2011 | 4 | 5 | 9 |
| 2012 | 9 | 0 | 9 |
| 2013 | 7 | 1 | 8 |
| 2014 | 7 | 2 | 9 |
| 2015 | 9 | 3 | 12 |
| 2016 | 13 | 4 | 17 |
| 2017 | 185 | 104 | 289 |
| 2018 | 141 | 109 | 250 |
| 2019 | 58 | 46 | 104 |
| 2020 | 3 | 9 | 12 |
| 2021 | 0 | 8 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepacivirus" by people in Profiles.
-
HIV and Hepatitis C Virus Screening in the Emergency Department and Linkage to Care During COVID-19: Challenges and Solutions. J Acquir Immune Defic Syndr. 2021 10 01; 88(2):e14-e16.
-
Impact of COVID-19 pandemic on hepatitis C elimination from the clinical microbiologist perspective. Are we ready? Enferm Infecc Microbiol Clin (Engl Ed). 2021 11; 39(9):475-476.
-
Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk? J Hepatol. 2022 02; 76(2):470-472.
-
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro. Antimicrob Agents Chemother. 2021 08 17; 65(9):e0268020.
-
Human Immunodeficiency Virus and Hepatitis C Linkage-to-Care Initiative for New Orleans Residents Experiencing Homelessness During the COVID-19 Pandemic. Sex Transm Dis. 2021 08 01; 48(8):595-600.
-
Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience. Rev Esp Enferm Dig. 2021 08; 113(8):624-625.
-
A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture. Microbiol Spectr. 2021 09 03; 9(1):e0043921.
-
Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis. Viruses. 2021 07 07; 13(7).
-
Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19. Liver Int. 2021 09; 41(9):2024-2031.
-
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy. J Hosp Infect. 2021 Sep; 115:51-58.